Contact
      Please use this form to send email to PR contact of this press release:
      
      Endonovo Restructures Business as Developers of Integrated AI Digital Health and Wellness Platform
    
      TO:
      
      Investor Relations
      
      Endonovo Therapeutics, Inc
      
      +1 877-796-1456